Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Other financing activities (2016 - 2025)

Anaptysbio (ANAB) has disclosed Other financing activities for 7 consecutive years, with $1.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other financing activities fell 79.66% year-over-year to $1.5 million, compared with a TTM value of $8.9 million through Dec 2025, up 18.86%, and an annual FY2025 reading of $1.5 million, down 80.66% over the prior year.
  • Other financing activities was $1.5 million for Q4 2025 at Anaptysbio, down from $7.1 million in the prior quarter.
  • Across five years, Other financing activities topped out at $7.1 million in Q4 2024 and bottomed at -$290000.0 in Q4 2022.
  • Average Other financing activities over 4 years is $995000.0, with a median of $43000.0 recorded in 2023.
  • Peak annual rise in Other financing activities hit 2050.0% in 2023, while the deepest fall reached 114.93% in 2023.
  • Year by year, Other financing activities stood at -$290000.0 in 2022, then surged by 85.17% to -$43000.0 in 2023, then skyrocketed by 16690.7% to $7.1 million in 2024, then crashed by 79.66% to $1.5 million in 2025.
  • Business Quant data shows Other financing activities for ANAB at $1.5 million in Q4 2025, $7.1 million in Q4 2024, and $334000.0 in Q3 2024.